Eli Lilly and Company Ends Alzheimer’s Study Contract With UC San Diego

by Vishnuprasad on  August 6, 2015 at 6:59 PM Mental Health News
RSS Email Print This Page Comment
In the latest blow to the University of California San Diego (UCSD) in its fight with the University of Southern California, the Eli Lilly and Company has reportedly decided to end its contract with the university for management of a landmark Alzheimer's study.
Eli Lilly and Company Ends Alzheimer’s Study Contract With UC San Diego
Eli Lilly and Company Ends Alzheimer’s Study Contract With UC San Diego
Advertisement

The development may cost million of dollars to the UCSD. The battle is for an A4 study, clinical trial testing solanezumab in the preclinical stage of Alzheimer's disease in older individuals.

Advertisement
The study has been managed by the Alzheimer's Disease Cooperative Study at UCSD. The study is funded by the Eli Lilly and Company, the National Institutes of Health and multiple philanthropic organizations.

Many members of the ADCS staff left UCSD this summer to join USC - sparking a UCSD lawsuit.

Recently, Judge Judith Hayes ruled that UCSD controlled the nationwide study, indicating that UCSD likely would prevail if the case went to trial.

But, last week, USC filed a countersuit against UCSD to try to regain control of the study.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive